GONAL-f CONSORT (Consistency in r-hFSH Starting Doses for Individualised Treatment)

• Status: Completed
• Trial end date: 2011-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

This non-interventional study (NIS) is planned to examine the consistency of the dose recommended by the doctor for the first stimulation day with the dose recommended by the CONSORT calculator.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck KGaA; Merck KGaA, Darmstadt, Germany
• Treatments: Follicle Stimulating Hormone; Hormones

Criteria

Inclusion Criteria:

• Female subjects undergoing stimulation with Gonal-f in ART in accordance with the permitted indication

• Subjects below 35 years of age

• Subjects who have a Body mass index below 30

• Subjects with a basal FSH below 12 I.E./l and is downregulated in the long gonadotropin hormone releasing hormone agonist (GnRHa) Protocol